The NEJM study showing the promising use of Remdesivir was funded by Gilead, had no control group, sample size was very small, and doctors submitted requests for compassionate use to Gilead so they selectively chose patients and excluded those with bad kidney or liver function.

It’s the job of the physician to be the ultimate skeptic because when we are wrong, the patient dies. If we push something based on flimsy evidence and false hope, people suffer. The New England Journal of Medicine should take its responsibility seriously and not sensationalize.

It’s also extremely circumspect that of the 61 patients in the study, 8 of them were thrown out. That’s 13% of the total study participants and a huge red flag. I mean there are literally more MD, DO, and PhD authors who wrote the study than there are patients in the study.